Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Testa

Showing results (581-590 of 588) with videos related to

Pageof 59
Sort By:
You have reached the last page of results.This site can display upto 588 results.
Elife|October 26, 2018
Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancerLili Liao, Zongzhi Z Liu, Lauren Langbein, et al.
Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.
Nature Communications|November 24, 2023
Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilitiesJohn J Krais, David J Glass, Ilse Chudoba, et al.
Oncogene|January 25, 2019
Thymine DNA glycosylase as a novel target for melanomaPietro Mancuso, Rossella Tricarico, Vikram Bhattacharjee, et al.
Molecular Cancer Therapeutics|August 5, 2020
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.
Molecular Cell|August 1, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
Journal of the National Cancer Institute|December 6, 2018
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families WorldwideSebastian Walpole, Antonia L Pritchard, Colleen M Cebulla, et al.
Pageof 59

Showing results (581-590 of 588) with videos related to

Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 588 results.
Elife|October 26, 2018
Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancerLili Liao, Zongzhi Z Liu, Lauren Langbein, et al.
Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.
Nature Communications|November 24, 2023
Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilitiesJohn J Krais, David J Glass, Ilse Chudoba, et al.
Oncogene|January 25, 2019
Thymine DNA glycosylase as a novel target for melanomaPietro Mancuso, Rossella Tricarico, Vikram Bhattacharjee, et al.
Molecular Cancer Therapeutics|August 5, 2020
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.
Molecular Cell|August 1, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
Journal of the National Cancer Institute|December 6, 2018
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families WorldwideSebastian Walpole, Antonia L Pritchard, Colleen M Cebulla, et al.
Pageof 59